内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Guardant Health, Inc.

GH · Nasdaq · CIK 0001576280 · Healthcare · Diagnostics & Research

内部人信号

当前没有活跃买入信号

1 qualifying P purchase group
当前 180 天评分窗口

209 同一窗口内观察到的 Form 4 交易行
77 sales · 131 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2026-06-15 · Kalia Kumud · $78.5K

为什么没有活跃信号？

买入活动存在
近期买入1 qualifying line group(s)
近期卖出High
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Azar Alex M IIDirector
○▼○▼
Talasaz AmirAliCo-Chief Executive Officer
○○○○
Eltoukhy HelmyCo-Chief Executive Officer
○○○○
Chudova DaryaChief Technology Officer
▼○○
Saia John G.Chief Legal Officer
○○
Monroe Terilyn J.Chief People Officer
○○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 7 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方1
买入集中度100%最大买方： Kalia Kumud · $78.5K
聚集买入 · 15天1 insider峰值活动： 2026-06-15–2026-06-15

Roles in the peak window: Chief Information Officer. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-06-15 · Kalia Kumud.

近期 Form 4 活动

1买入
140卖出
305其他 Form 4 交易行
159SEC 申报 · 365天
买入1 qualifying P line(s) · 180 days
卖出77 sale line(s) · 仅供背景
其他131 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
11,915,002
上期报告
11,018,331
日均成交量
1,920,986
回补天数
6.2

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-06-15Kalia Kumud买入 (P)Common Stock600USD 130.76USD 78,456SEC 申报 ↗
2024-03-18Kalia Kumud买入 (P)Common Stock2,187USD 17.82USD 38,972SEC 申报 ↗
2023-06-09Kalia Kumud买入 (P)COMMON STOCK2,981USD 32.71USD 97,494SEC 申报 ↗
2023-03-15Eltoukhy Helmy买入 (P)COMMON STOCK8,600USD 26.15USD 224,890SEC 申报 ↗
2023-03-14Eltoukhy Helmy买入 (P)COMMON STOCK84,452USD 26.33USD 2,223,621SEC 申报 ↗
2023-03-14Talasaz AmirAli买入 (P)COMMON STOCK12,750USD 26.40USD 336,600SEC 申报 ↗
2023-03-13Talasaz AmirAli买入 (P)COMMON STOCK60,000USD 25.66USD 1,539,366SEC 申报 ↗
2021-11-23Talasaz AmirAli买入 (P)COMMON STOCK54,500USD 94.33USD 5,141,241SEC 申报 ↗
2021-11-23Eltoukhy Helmy买入 (P)COMMON STOCK54,500USD 94.35USD 5,142,231SEC 申报 ↗
2021-11-19Talasaz AmirAli买入 (P)COMMON STOCK50,000USD 98.06USD 4,902,788SEC 申报 ↗
2021-11-19Eltoukhy Helmy买入 (P)COMMON STOCK50,000USD 98.11USD 4,905,548SEC 申报 ↗

Form 4 申报证据

446 transaction lines in the latest 365-day window; 1,673 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-10-14Azar Alex M II卖出 (S)Common Stock69USD 159.89USD 11,032SEC 申报 ↗
2026-10-12Azar Alex M II期权行权／转换 (M)Common Stock137USD 0.00USD 0SEC 申报 ↗
2026-10-01Talasaz AmirAli期权行权／转换 (M)Common Stock33,713USD 0.00USD 0SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-10-14Azar Alex M II卖出 (S)Common Stock69USD 159.89USD 11,032SEC 申报 ↗
2026-10-12Azar Alex M II期权行权／转换 (M)Common Stock137USD 0.00USD 0SEC 申报 ↗
2026-10-01Talasaz AmirAli期权行权／转换 (M)Common Stock33,713USD 0.00USD 0SEC 申报 ↗
2026-10-01Talasaz AmirAli代扣税 (F)Common Stock17,087USD 174.75USD 2,985,953SEC 申报 ↗
2026-10-01Saia John G.期权行权／转换 (M)Common Stock7,063USD 0.00USD 0SEC 申报 ↗
2026-10-01Saia John G.代扣税 (F)Common Stock3,706USD 174.75USD 647,624SEC 申报 ↗
2026-10-01Monroe Terilyn J.期权行权／转换 (M)Common Stock4,019USD 0.00USD 0SEC 申报 ↗
2026-10-01Monroe Terilyn J.代扣税 (F)Common Stock2,098USD 174.75USD 366,626SEC 申报 ↗
2026-10-01Kalia Kumud期权行权／转换 (M)Common Stock6,046USD 0.00USD 0SEC 申报 ↗
2026-10-01Kalia Kumud代扣税 (F)Common Stock3,067USD 174.75USD 535,958SEC 申报 ↗
2026-10-01Freeman Chris期权行权／转换 (M)Common Stock7,416USD 0.00USD 0SEC 申报 ↗
2026-10-01Freeman Chris代扣税 (F)Common Stock3,143USD 174.75USD 549,239SEC 申报 ↗
2026-10-01Eltoukhy Helmy期权行权／转换 (M)Common Stock33,713USD 0.00USD 0SEC 申报 ↗
2026-10-01Eltoukhy Helmy代扣税 (F)Common Stock17,087USD 174.75USD 2,985,953SEC 申报 ↗
2026-10-01Chudova Darya期权行权／转换 (M)Common Stock8,033USD 0.00USD 0SEC 申报 ↗
2026-10-01Chudova Darya代扣税 (F)Common Stock4,320USD 174.75USD 754,920SEC 申报 ↗
2026-10-01Bell Michael Brian期权行权／转换 (M)Common Stock7,280USD 0.00USD 0SEC 申报 ↗
2026-10-01Bell Michael Brian代扣税 (F)Common Stock3,914USD 174.75USD 683,972SEC 申报 ↗
2026-09-30Talasaz AmirAli期权行权／转换 (M)Common Stock2,817USD 0.00USD 0SEC 申报 ↗
2026-09-30Talasaz AmirAli代扣税 (F)Common Stock1,428USD 178.36USD 254,698SEC 申报 ↗
2026-09-30Eltoukhy Helmy期权行权／转换 (M)Common Stock2,817USD 0.00USD 0SEC 申报 ↗
2026-09-30Eltoukhy Helmy代扣税 (F)Common Stock1,428USD 178.36USD 254,698SEC 申报 ↗
2026-09-21MIGNONE ROBERTO期权行权／转换 (M)Common Stock264USD 0.00USD 0SEC 申报 ↗
2026-09-17Hidalgo Medina Manuel期权行权／转换 (M)Common Stock232USD 0.00USD 0SEC 申报 ↗
2026-09-16Tariq Musa卖出 (S)Common Stock116USD 175.00USD 20,300SEC 申报 ↗
2026-09-16Krognes Steve E.卖出 (S)Common Stock6,674USD 175.74USD 1,172,890SEC 申报 ↗
2026-09-16Azar Alex M II卖出 (S)Common Stock826USD 175.00USD 144,550SEC 申报 ↗
2026-09-15Tariq Musa期权行权／转换 (M)Common Stock249USD 0.00USD 0SEC 申报 ↗
2026-09-15Chudova Darya卖出 (S)Common Stock7,738USD 178.00USD 1,377,364SEC 申报 ↗
2026-09-12Azar Alex M II期权行权／转换 (M)Common Stock1,651USD 0.00USD 0SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码GH
CIK0001576280
行业Healthcare
细分行业Diagnostics & Research Yahoo Finance
SEC SIC8071 Services-Medical Laboratories
交易所Nasdaq

数据覆盖

本地 Form 4 历史1,673 transaction lines from 2020-01-03 to 2026-10-14
28 P purchase lines · 636 S sale lines · 1,009 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.